{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:33:41Z","timestamp":1791387221574,"version":"4.3.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Nil"],"award-info":[{"award-number":["Nil"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13312-026-00422-4","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:13:53Z","timestamp":1787123633000},"page":"814-820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Efficacy, Safety, and Cost of Different Intrapleural Fibrinolytic Agents for the Management of Empyema Thoracis in Children: A Systematic Review"],"prefix":"10.1007","volume":"63","author":[{"given":"Meenakshi","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hardeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounika","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-2623","authenticated-orcid":false,"given":"Joseph L.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"422_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1086\/338460","volume":"34","author":"CL Byington","year":"2002","unstructured":"Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34:434\u201340.","journal-title":"Clin Infect Dis"},{"key":"422_CR2","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","volume":"53","author":"JS Bradley","year":"2011","unstructured":"Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants a children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis. 2011;53:e25-76.","journal-title":"Clin Infect Dis"},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/650573","volume":"50","author":"CG Grijalva","year":"2010","unstructured":"Grijalva CG, Nuorti JP, Zhu Y, Griffin MR. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis. 2010;50:805\u201313.","journal-title":"Clin Infect Dis"},{"key":"422_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","volume":"25","author":"JG Liese","year":"2010","unstructured":"Liese JG, Schoen C, van der Linden M, et al. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010\u20132017: a nationwide surveillance study. Clin Microbiol Infect. 2010;25:857\u201364.","journal-title":"Clin Microbiol Infect"},{"key":"422_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/jpids\/piy103","volume":"8","author":"F Madhi","year":"2019","unstructured":"Madhi F, Levy C, Morin L, et al. Change in bacterial causes of community-acquired parapneumonic effusion and pleural empyema in children 6 years after 13-valent pneumococcal conjugate vaccine implementation. J Pediatr Infect Dis Soc. 2019;8:474\u20137.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"422_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1513\/pats.200510-113JH","volume":"3","author":"RW Light","year":"2006","unstructured":"Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3:75\u201380.","journal-title":"Proc Am Thorac Soc"},{"issue":"Suppl 1","key":"422_CR7","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thx.2004.030676","volume":"60","author":"IM Balfour-Lynn","year":"2005","unstructured":"Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS Guidelines for the management of pleural infection in children. Thorax. 2005;60(Suppl 1):i1-21.","journal-title":"Thorax"},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/sur.2016.134","volume":"18","author":"MK Richards","year":"2017","unstructured":"Richards MK, McAteer JP, Edwards TC, et al. Establishing equipoise: national survey of the treatment of pediatric para-pneumonic effusion and empyema. Surg Infect (Larchmt). 2017;18:137\u201342.","journal-title":"Surg Infect (Larchmt)"},{"key":"422_CR9","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/j.jpedsurg.2012.07.047","volume":"47","author":"S Islam","year":"2012","unstructured":"Islam S, Calkins CM, Goldin AB, et al. The diagnosis and management of empyema in children: a comprehensive review from the APSA outcomes and clinical trials committee. J Pediatr Surg. 2012;47:2101\u201310.","journal-title":"J Pediatr Surg"},{"key":"422_CR10","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1172\/JCI102046","volume":"28","author":"WS Tillett","year":"1949","unstructured":"Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest. 1949;28:173\u201390.","journal-title":"J Clin Invest"},{"key":"422_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJMoa042473","volume":"352","author":"NA Maskell","year":"2005","unstructured":"Maskell NA, Davies CW, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865\u201374.","journal-title":"N Engl J Med"},{"key":"422_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1378\/chest.123.2.432","volume":"123","author":"T Laisaar","year":"2003","unstructured":"Laisaar T, Pullerits T. Effect of intrapleural streptokinase administration on antistreptokinase antibody level in patients with loculated pleural effusions. Chest. 2003;123:432\u20135.","journal-title":"Chest"},{"key":"422_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/thorax.57.4.343","volume":"57","author":"AH Thomson","year":"2002","unstructured":"Thomson AH, Hull J, Kumar MR, Wallis C, Balfour Lynn IM. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax. 2002;57:343\u20137.","journal-title":"Thorax"},{"key":"422_CR14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1651-2227.2004.tb02626.x","volume":"93","author":"M Singh","year":"2004","unstructured":"Singh M, Mathew JL, Chandra S, Katariya S, Kumar L. Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children. Acta Paediatr. 2004;93:1443\u20135.","journal-title":"Acta Paediatr"},{"key":"422_CR15","doi-asserted-by":"publisher","DOI":"10.5812\/ijp.3154","volume":"25","author":"K Bose","year":"2015","unstructured":"Bose K, Saha S, Mridha D, Das K, Mondal P, Das I. Analysis of outcome of intraplueral streptokinase in pediatric empyema thoracis even in advanced stages: a prospective study. Iran J Pediatr. 2015;25:e3154.","journal-title":"Iran J Pediatr"},{"key":"422_CR16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1111\/apa.14408","volume":"107","author":"JL Mathew","year":"2018","unstructured":"Mathew JL, Soni V, Singh M, et al. Intrapleural streptokinase is effective and safe for children with multi-loculated empyema regardless of the time from disease onset. Acta Paediatr. 2018;107:2165\u201371.","journal-title":"Acta Paediatr"},{"key":"422_CR17","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/ppul.23184","volume":"50","author":"SJ Hanson","year":"2015","unstructured":"Hanson SJ, Havens PL, Simpson PM, Nugent ML, Wells RG. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation. Pediatr Pulmonol. 2015;50:1328\u201335.","journal-title":"Pediatr Pulmonol"},{"key":"422_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa1012740","volume":"365","author":"NM Rahman","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518\u201326.","journal-title":"N Engl J Med"},{"key":"422_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/jamapediatrics.2019.5863","volume":"174","author":"MH Livingston","year":"2020","unstructured":"Livingston MH, Mahant S, Connolly B, et al. Effectiveness of Intrapleural tissue plasminogen activator and dornase alfa vs tissue plasminogen activator alone in children with pleural empyema: a randomized clinical trial. JAMA Pediatr. 2020;174:332\u201340.","journal-title":"JAMA Pediatr"},{"key":"422_CR20","doi-asserted-by":"crossref","unstructured":"Altmann ES, Crossingham I, Wilson S, Davies HR. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019.","DOI":"10.1002\/14651858.CD002312.pub4"},{"key":"422_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jpedsurg.2008.10.018","volume":"44","author":"SD St Peter","year":"2009","unstructured":"St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication versus tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg. 2009;44:106\u201311.","journal-title":"J Pediatr Surg"},{"key":"422_CR22","volume":"3","author":"MD Redden","year":"2017","unstructured":"Redden MD, Chin TY, van Driel ML. Surgical versus non-surgical management for pleural empyema. Cochrane Database Syst Rev. 2017;3:CD010651.","journal-title":"Cochrane Database Syst Rev"},{"key":"422_CR23","unstructured":"Malik M, Pradhan P, Bhatt S et al. Comparative efficacy and safety of different intrapleural fibrinolytic agents for the management of empyema in children: A systematic review and meta-analysis. PROSPERO. Available from https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024515696. Accessed 29 July 2026."},{"key":"422_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"422_CR25","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.5. 2024. Available from: https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"422_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1055\/s-0039-1694699","volume":"40","author":"MS Godfrey","year":"2019","unstructured":"Godfrey MS, Bramley KT, Detterbeck F. Medical and surgical management of empyema. Semin Respir Crit Care Med. 2019;40:361\u201374.","journal-title":"Semin Respir Crit Care Med"},{"key":"422_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74:785\u201394.","journal-title":"Biometrics"},{"key":"422_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"422_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1164\/ajrccm.155.1.9001327","volume":"155","author":"D Bouros","year":"1997","unstructured":"Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"422_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00408-015-9807-6","volume":"193","author":"C Aleman","year":"2015","unstructured":"Aleman C, Porcel JM, Alegre J, et al. Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: a prospective randomized study. Lung. 2015;193:993\u20131000.","journal-title":"Lung"},{"key":"422_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4046\/trd.2022.0168","volume":"87","author":"S Adhikari","year":"2024","unstructured":"Adhikari S, Marwah V, Choudhary R, et al. Intrapleural fibrinolysis with urokinase versus alteplase in complicated pleural effusions and empyema: a prospective randomized controlled trial. Tuberc Respir Dis. 2024;87:378\u201385.","journal-title":"Tuberc Respir Dis"},{"key":"422_CR32","doi-asserted-by":"crossref","unstructured":"Sarafi M, Mohajerzadeh L, Ebrahimian M, et al. The efficacy of intrapleural fibrinolytic agents following surgical intervention for empyema thoracis: a prospective cross-sectional study in a pediatric population. Iran J Pediatr 2023;33(4).","DOI":"10.5812\/ijp-136509"},{"key":"422_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00383-004-1214-7","volume":"20","author":"R Ulku","year":"2004","unstructured":"Ulku R, Onen A, Onat S, Kilinc N, Ozcelik C. Intrapleural fibrinolytic treatment of multiloculated pediatric empyemas. Pediatr Surg Int. 2004;20:520\u20134.","journal-title":"Pediatr Surg Int"},{"key":"422_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1148\/radiol.2282020486","volume":"228","author":"RG Wells","year":"2003","unstructured":"Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003;228:370\u20138.","journal-title":"Radiology"},{"key":"422_CR35","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.chest.2023.06.010","volume":"164","author":"CF Elviro","year":"2023","unstructured":"Elviro CF, Longcroft-Harris B, Allin E, Leache L, et al. Conservative and surgical modalities in the management of pediatric parapneumonic effusion and empyema: a living systematic review and network meta-analysis. Chest. 2023;164:1125\u201338.","journal-title":"Chest"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-026-00422-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-026-00422-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:40:58Z","timestamp":1791344458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-026-00422-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1007\/s13312-026-00422-4","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The protocol of the systematic review was registered in the PROSPERO database (ID: CRD42024515696) dated March 2nd, 2024.","order":2,"name":"Ethics","label":"Registry","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"No generative artificial intelligence (AI) tools were used in the writing, editing, data analysis, or figure generation for this manuscript. All content is the original work of the authors.","order":3,"name":"Ethics","label":"Use of Artificial Intelligence (AI) Tools for Scientific Writing","group":{"name":"EthicsHeading","label":"Ethics"}}]}}